Pharma risk-sharing scheme a 'costly failure'

2010-06-04T09:51:00

A trial project to provide patients with information to make better treatment decisions has been launched by NHS Direct.

A risk-sharing agreement between the government and drug companies to supply expensive multiple sclerosis medicines was a “costly failure”, experts have claimed.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here